Bayer says its drug extends lives of liver cancer patients
May 04, 2016 at 13:32 PM EDT
FRANKFURT, May 4 (Reuters) - Bayer AG said on Thursday its Regorafenib cancer treatment drug helped extend the lives of liver cancer sufferers according to the results of a Phase III clinical trial.
